We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$2.77B
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.67% |
| 2 | Financials | 16.99% |
| 3 | Technology | 16.42% |
| 4 | Miscellaneous | 11.36% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Qiagen
QGEN
$8.75B
| $103M | 0.21% |
2,082,073
+283,834
| +16% | +$13.8M |
|
|
PXD
102
DELISTED
Pioneer Natural Resource Co.
PXD
| $101M | 0.21% |
453,845
+382,106
| +533% | +$96.9M |
|
103
AstraZeneca
AZN
$248B
| $98.8M | 0.2% |
747,883
-227,477
| -23% | -$29.8M |
|
104
Bilibili
BILI
$6.78B
| $98.2M | 0.2% |
3,836,394
+1,770,062
| +86% | +$42.6M |
|
105
MongoDB
MDB
$28.7B
| $96.5M | 0.2% |
371,862
+69,811
| +23% | +$21.8M |
|
106
Deutsche Bank
DB
$77.2B
| $95.9M | 0.2% |
11,018,732
+8,734,414
| +382% | +$93.2M |
|
107
Goldman Sachs
GS
$302B
| $95.7M | 0.2% |
322,145
-333,089
| -51% | -$104M |
|
108
Paycom
PAYC
$9.88B
| $95M | 0.2% |
339,092
+53,770
| +19% | +$15.9M |
|
109
T-Mobile US
TMUS
$195B
| $94.5M | 0.19% |
702,373
+416,430
| +146% | +$54.3M |
|
|
SPR
110
DELISTED
Spirit AeroSystems
SPR
| $92.2M | 0.19% |
3,148,209
+580,518
| +23% | +$20.8M |
|
|
SF
111
Stifel
SF
$12.2B
| $92.1M | 0.19% |
2,467,172
+502,310
| +26% | +$20.9M |
|
112
United Rentals
URI
$63.2B
| $92.1M | 0.19% |
379,221
+98,828
| +35% | +$29.1M |
|
113
JB Hunt Transport Services
JBHT
$25.8B
| $91.4M | 0.19% |
580,634
+471,753
| +433% | +$79.8M |
|
114
CALL
Netflix
NFLX
$320B
| $90.7M | 0.19% |
5,186,000
+3,911,000
| +307% | +$86.7M |
|
|
CTXS
115
DELISTED
Citrix Systems Inc
CTXS
| $89.7M | 0.18% |
923,587
-127,763
| -12% | -$12.7M |
|
116
Moderna
MRNA
$56B
| $89.4M | 0.18% |
625,755
-183,380
| -23% | -$26.2M |
|
|
TWTR
117
DELISTED
Twitter, Inc.
TWTR
| $89.3M | 0.18% |
2,387,773
+2,141,149
| +868% | +$91.9M |
|
|
118
Netflix
NFLX
$320B
| $89.2M | 0.18% |
5,101,830
+4,163,590
| +444% | +$92.3M |
|
|
IAA
119
DELISTED
IAA, Inc. Common Stock
IAA
| $88.5M | 0.18% |
2,701,876
+1,787,724
| +196% | +$65.5M |
|
120
Marriott International
MAR
$85.7B
| $87.9M | 0.18% |
646,628
-555,848
| -46% | -$91.8M |
|
121
Copa Holdings
CPA
$5.3B
| $87.7M | 0.18% |
1,383,429
-77,882
| -5% | -$5.49M |
|
122
Cisco
CSCO
$430B
| $86.6M | 0.18% |
2,031,847
+2,028,041
| +53,285% | +$97.1M |
|
123
Ulta Beauty
ULTA
$23.5B
| $86M | 0.18% |
223,157
+138,267
| +163% | +$54.9M |
|
124
PUT
Walmart Inc
WMT
$841B
| $84.7M | 0.17% |
2,090,700
-3,813,600
| -65% | -$176M |
|
125
General Mills
GIS
$20.2B
| $83.9M | 0.17% |
1,111,408
+806,928
| +265% | +$56.5M |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $2.77B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.